Polpharma Forms Alliance With Neuraxpharm To Develop Biosimilars

News: Polish pharmaceutical company Polpharma has signed an agreement with Germany-based Neuraxpharm to jointly develop and market biosimilars, reports CeePharma. Under the terms of the agreement, both companies will jointly share the costs and risks in the development of biosimilars. The agreement also grants them rights to future drugs.

This article is tagged to:
Related sectors of this article: Pharmaceuticals & Healthcare, R&D, Agreements - Pharmaceuticals
Geography: Poland

Enter your details to read the full article

By submitting this form you are acknowledging that you have read and understood our Privacy Policy.